Patents by Inventor Elizabeth M. ALLEN

Elizabeth M. ALLEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KINASE INHIBITOR
    Publication number: 20140142110
    Abstract: The invention is directed to a compound of formula (I): and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
    Type: Application
    Filed: January 28, 2014
    Publication date: May 22, 2014
    Applicant: SANOFI
    Inventors: Timothy A. GILLESPY, Elizabeth M. ALLEN, Kin T. YU, Asher ZILBERSTEIN
  • Kinase inhibitor
    Patent number: 8658649
    Abstract: The invention is directed to a compound of formula (I): and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: February 25, 2014
    Assignee: Sanofi
    Inventors: Timothy A. Gillespy, Paul Eynott, Elizabeth M. Allen, Kin T. Yu, Asher Zilberstein
  • TREATMENT FOR GLOMERULONEPHRITIS WITH 2-[4-(7-ETHYL-5H-PYRROLO[2,3-B]PYRAZIN-6-YL)PHENYL]PROPAN-2-OL
    Publication number: 20110251219
    Abstract: A treatment for glomerulonephritis, and other renal dysfunctions using a compound of Formula I is disclosed.
    Type: Application
    Filed: June 2, 2011
    Publication date: October 13, 2011
    Applicant: SANOFI
    Inventors: Thomas OLIGINO, Timothy A. GILLESPY, Ramalinga DHARANIPRAGADA, Elizabeth M. ALLEN
  • KINASE INHIBITOR
    Publication number: 20100035884
    Abstract: The invention is directed to a compound of formula (I): and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
    Type: Application
    Filed: March 10, 2009
    Publication date: February 11, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Timothy A. GILLESPY, Paul EYNOTT, Elizabeth M. ALLEN, Kin T. YU, Asher ZILBERSTEIN